{"id":1021015,"date":"2026-11-13T16:08:11","date_gmt":"2026-11-13T21:08:11","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\/"},"modified":"2026-11-13T16:08:11","modified_gmt":"2026-11-13T21:08:11","slug":"evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\/","title":{"rendered":"Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)<\/b><\/p>\n<p>NEWPORT BEACH, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2FEvolus.com&amp;esheet=54639402&amp;newsitemid=20261113769939&amp;lan=en-US&amp;anchor=Evolus%2C+Inc.&amp;index=1&amp;md5=ea5ddc9b21cba7d256708f9a03d8c8d7\">Evolus, Inc.<\/a> (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant during August 2026 to November 2026 of an aggregate of 194,335 restricted stock units (RSUs) of the company\u2019s common stock to 25 newly hired non-executive employees.<\/p>\n<p>\nThe RSUs vest 25% on each anniversary of the vesting commencement date, subject to each employee\u2019s continued service and the terms of the 2023 Inducement Incentive Plan and the applicable RSU agreement. The awards were approved by the compensation committee of the company\u2019s board of directors under Evolus\u2019 2023 Inducement Incentive Plan as inducements material to the new employees entering into employment with Evolus in accordance with Nasdaq Listing Rule 5635(c)(4).<\/p>\n<p><b>About Evolus, Inc.<\/b><\/p>\n<p>\nEvolus (NASDAQ: EOLS) is a global performance beauty company redefining the aesthetic injectable market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global leader in aesthetics by building a differentiated portfolio of injectable brands that address the evolving needs of practitioners and patients. Our portfolio includes Jeuveau<sup>\u00ae<\/sup> (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics, Evolysse<sup>\u00ae<\/sup>, a collection of unique injectable hyaluronic acid (HA) gels, and Profhilo<sup>\u00ae<\/sup>, the market-leading injectable for skin quality in Europe, which Evolus has exclusively licensed for development and commercialization in the United States. Visit us at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.evolus.com%2F&amp;esheet=54639402&amp;newsitemid=20261113769939&amp;lan=en-US&amp;anchor=www.evolus.com&amp;index=2&amp;md5=ce1a125aaf08f966f6fd2f0734293ece\">www.evolus.com<\/a>, and follow us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fevolusaesthetic&amp;esheet=54639402&amp;newsitemid=20261113769939&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=3&amp;md5=f94b45e7b441590b9befaef01a53d9f1\">LinkedIn<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FEvolusAesthetic&amp;esheet=54639402&amp;newsitemid=20261113769939&amp;lan=en-US&amp;anchor=X&amp;index=4&amp;md5=974eb10d92180d2b03383c73aec08320\">X<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fevolus%2F&amp;esheet=54639402&amp;newsitemid=20261113769939&amp;lan=en-US&amp;anchor=Instagram&amp;index=5&amp;md5=d1527987930aca2c268ed80549cddb06\">Instagram<\/a> or <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2Fevolusaesthetic%2F&amp;esheet=54639402&amp;newsitemid=20261113769939&amp;lan=en-US&amp;anchor=Facebook&amp;index=6&amp;md5=5ced664e0482ce539a823ecf062f24e9\">Facebook<\/a>.<\/p>\n<p>\nJeuveau<sup>\u00ae<\/sup>, Nuceiva<sup>\u00ae<\/sup>, and Evolysse<sup>\u00ae<\/sup> are registered trademarks of Evolus, Inc.<br \/>\n<br \/>Profhilo<sup>\u00ae<\/sup> is a registered trademark of IBSA Institut Biochimique SA.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261113769939r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20261113769939\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20261113769939\/en\/<\/a><\/span><\/p>\n<p><strong>Evolus Contacts:<br \/>\n<\/strong><br \/><strong><span class=\"bwuline\">Investors:<br \/>\n<\/span><\/strong><br \/>Nareg Sagherian<br \/>\n<br \/>Vice President, Head of Global Investor Relations and Corporate Communications<br \/>\n<br \/>Tel: 248-202-9267<br \/>\n<br \/>Email: <a rel=\"nofollow\" href=\"mailto:ir@evolus.com\">ir@evolus.com<\/a><\/p>\n<p><span class=\"bwuline\">Media<\/span>:<br \/>\n<br \/>Email: <a rel=\"nofollow\" href=\"mailto:media@evolus.com\">media@evolus.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America California<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Cosmetics Retail Pharmaceutical Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20261113769939\/en\/1788236\/3\/LOGO_NEW_SMALL.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) NEWPORT BEACH, Calif.&#8211;(BUSINESS WIRE)&#8211;Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant during August 2026 to November 2026 of an aggregate of 194,335 restricted stock units (RSUs) of the company\u2019s common stock to 25 newly hired non-executive employees. The RSUs vest 25% on each anniversary of the vesting commencement date, subject to each employee\u2019s continued service and the terms of the 2023 Inducement Incentive Plan and the applicable RSU agreement. The awards were approved by the compensation committee of the company\u2019s board of directors under Evolus\u2019 2023 Inducement Incentive Plan as inducements material to the new &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1021015","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) NEWPORT BEACH, Calif.&#8211;(BUSINESS WIRE)&#8211;Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant during August 2026 to November 2026 of an aggregate of 194,335 restricted stock units (RSUs) of the company\u2019s common stock to 25 newly hired non-executive employees. The RSUs vest 25% on each anniversary of the vesting commencement date, subject to each employee\u2019s continued service and the terms of the 2023 Inducement Incentive Plan and the applicable RSU agreement. The awards were approved by the compensation committee of the company\u2019s board of directors under Evolus\u2019 2023 Inducement Incentive Plan as inducements material to the new &hellip; Continue reading &quot;Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-13T21:08:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261113769939r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)\",\"datePublished\":\"2026-11-13T21:08:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\\\/\"},\"wordCount\":338,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20261113769939r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\\\/\",\"name\":\"Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20261113769939r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-11-13T21:08:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20261113769939r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20261113769939r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\/","og_locale":"en_US","og_type":"article","og_title":"Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Market Newsdesk","og_description":"Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) NEWPORT BEACH, Calif.&#8211;(BUSINESS WIRE)&#8211;Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant during August 2026 to November 2026 of an aggregate of 194,335 restricted stock units (RSUs) of the company\u2019s common stock to 25 newly hired non-executive employees. The RSUs vest 25% on each anniversary of the vesting commencement date, subject to each employee\u2019s continued service and the terms of the 2023 Inducement Incentive Plan and the applicable RSU agreement. The awards were approved by the compensation committee of the company\u2019s board of directors under Evolus\u2019 2023 Inducement Incentive Plan as inducements material to the new &hellip; Continue reading \"Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-13T21:08:11+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261113769939r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","datePublished":"2026-11-13T21:08:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\/"},"wordCount":338,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261113769939r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\/","name":"Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261113769939r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-11-13T21:08:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261113769939r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261113769939r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1021015","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1021015"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1021015\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1021015"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1021015"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1021015"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}